| 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|
| 上市前/上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 |
| 流动资产： | |||
| 货币资金(元) | 321,817.69 | 1,257,058.75 | 5,139,587.07 |
| 应收票据及应收账款(元) | 355,359,598.71 | 335,868,081.92 | 368,905,310.22 |
| 其中：应收票据(元) | - | - | 5,000,000.00 |
| 其中：应收账款(元) | 355,359,598.71 | 335,868,081.92 | 363,905,310.22 |
| 预付款项(元) | 2,714,126.57 | 1,885,620.15 | 8,876,397.76 |
| 其他应收款(元) | 8,249,134.38 | 22,453,552.44 | 22,081,719.07 |
| 存货(元) | 24,538,260.16 | 22,876,220.38 | 38,341,739.77 |
| 流动资产合计(元) | 391,182,937.51 | 384,340,533.64 | 443,344,753.89 |
| 非流动资产： | |||
| 长期股权投资(元) | -286,121.39 | -286,121.39 | -238,421.39 |
| 固定资产(元) | 142,364,776.55 | 147,022,859.25 | 145,846,808.78 |
| 在建工程(元) | - | - | 4,876,573.43 |
| 生产性生物资产(元) | 6,080,248.94 | 6,284,056.10 | 6,487,863.26 |
| 使用权资产(元) | 2,172,477.92 | 9,533,217.72 | 2,304,044.60 |
| 无形资产(元) | 9,418,030.62 | 2,238,261.26 | 9,648,404.82 |
| 长期待摊费用(元) | - | - | 43,689.26 |
| 递延所得税资产(元) | 6,090,020.38 | 5,862,347.03 | 5,872,889.19 |
| 其他非流动资产(元) | 2,500,000.00 | 2,500,000.00 | 2,500,000.00 |
| 非流动资产合计(元) | 168,339,433.02 | 173,154,619.97 | 177,341,851.95 |
| 资产总计(元) | 559,522,370.53 | 557,495,153.61 | 620,686,605.84 |
| 流动负债： | |||
| 短期借款(元) | 90,000,000.00 | 93,300,000.00 | 140,000,000.00 |
| 应付票据及应付账款(元) | 175,764,649.65 | 167,099,913.64 | 259,976,010.94 |
| 其中：应付票据(元) | - | - | 6,000,000.00 |
| 其中：应付账款(元) | 175,764,649.65 | 167,099,913.64 | 253,976,010.94 |
| 预收款项(元) | 182,183.94 | 130,827.20 | 30,827.20 |
| 合同负债(元) | 634,420.73 | 634,420.73 | 634,420.73 |
| 应付职工薪酬(元) | 3,327,840.65 | 4,014,240.04 | 1,871,558.45 |
| 应交税费(元) | 71,005,279.32 | 75,331,288.31 | 46,823,731.57 |
| 其他应付款(元) | 147,826,209.41 | 147,055,362.78 | 102,285,024.06 |
| 其他流动负债(元) | 82,474.70 | 82,474.70 | 82,474.70 |
| 流动负债合计(元) | 488,823,058.40 | 487,648,527.40 | 551,704,047.65 |
| 非流动负债： | |||
| 递延收益(元) | 3,368,500.00 | 3,562,000.00 | 3,755,500.00 |
| 非流动负债合计(元) | 3,368,500.00 | 3,562,000.00 | 3,755,500.00 |
| 负债合计(元) | 492,191,558.40 | 491,210,527.40 | 555,459,547.65 |
| 所有者权益(或股东权益)： | |||
| 实收资本或股本(元) | 42,000,000.00 | 42,000,000.00 | 42,000,000.00 |
| 资本公积(元) | 11,568,985.60 | 11,568,985.60 | 11,568,985.60 |
| 盈余公积(元) | 1,600,900.06 | 1,600,900.06 | 1,397,330.24 |
| 未分配利润(元) | 12,144,257.23 | 11,062,012.95 | 10,266,560.56 |
| 归属于母公司股东权益合计(元) | 67,314,142.89 | 66,231,898.61 | 65,232,876.40 |
| 少数股东权益(元) | 16,669.24 | 52,727.60 | -5,818.21 |
| 股东权益合计(元) | 67,330,812.13 | 66,284,626.21 | 65,227,058.19 |
| 负债和股东权益合计(元) | 559,522,370.53 | 557,495,153.61 | 620,686,605.84 |
| 公告日期 | 2023-08-16 | 2023-04-27 | 2022-08-17 |
| 审计意见(境内) | 保留意见 | ||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |